Clinical trial
Double-Blind Placebo-Controlled Study Comparing the Combination of 15% SP-303 Gel With Acyclovir Versus Acyclovir Alone for the Treatment of Recurrent Herpes Simplex Virus (HSV) Infections in Subjects With Acquired Immunodeficiency Syndrome (AIDS)
NCT00002186
Study timeline
Registry last updated2005-06-24
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Herpes Simplexunresolved
HIV Infectionsunresolved
Interventions
CrofelemerDRUG · verified · RxNorm: crofelemer
AcyclovirDRUG · verified · RxNorm: acyclovir
Sponsors & collaborators
Shaman Pharmaceuticalslead sponsor
Mapped research locations
New YorkNew York, United States4BaltimoreMaryland, United States2San FranciscoCalifornia, United States2SeattleWashington, United States2HoustonTexas, United States1BostonMassachusetts, United States1ChicagoIllinois, United States1Los AngelesCalifornia, United States1PhiladelphiaPennsylvania, United States1DallasTexas, United States1BirminghamAlabama, United States1TampaFlorida, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00002186 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.